Companies / RenovoRx, Inc.

RenovoRx, Inc.

Nasdaq: RNXTCIK 1574094MOUNTAIN VIEW, CA

Financials · FY2025

Revenue$1.12M
Net income$-11.17M
Total debt
Cash$9.48M
Diluted EPS$-0.32
Shares outstanding45.1M

Ownership

45.1M shares outstanding · as of Mar 23, 2026
3.2%Insiders
Ownership
Insiders3.24%1,458,282
10%+ / strategic5.80%2,615,193
Institutions18.14%8,170,914
Public float72.82%32,808,317

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 5

View all →
Insider% of sharesShares
Agah RamtinChief Medical Officer · Director
1.77%798,460
Bagai ShaunCEOChief Executive Officer · Director
0.70%313,357
Voll MarkChief Financial Officer
0.53%239,580
Ryan Una SDirector
0.22%97,165
0.02%9,720

Institutional holders 35

View all →

Activity

InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Mar 3, 2022Ryan Una S
Director
OtherCommon Stock$200.2K+48K
47,789
0.11% of shares
low
Apr 22, 2022Ryan Una S
Director
OtherCommon Stock$26.3K+16K
+20.02%
97,165
0.22% of shares
low
Mar 3, 2022Ryan Una S
Director
OtherCommon Stock$25.0K+6K
+13.25%
54,121
0.12% of shares
low
Apr 22, 2022Ryan Una S
Director
OtherCommon Stock$25.0K+27K
+49.59%
80,959
0.18% of shares
low
May 19, 2026Voll Mark
Executive
BuyCommon Stock$19.7K+25K
+21.30%
142,380
0.32% of shares
low
Jan 21, 2026Agah Ramtin
Executive
BuyCommon Stock$10.0K+10K
+1.27%
798,460
1.77% of shares
low
Dec 31, 2025Agah Ramtin
Executive
BuyCommon Stock$8.4K+10K
+1.26%
788,460
1.75% of shares
low
Dec 30, 2025Agah Ramtin
Executive
BuyCommon Stock$169+205
+0.03%
778,665
1.73% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Orin HirschmanPassive13G/A2,615,193
Orin HirschmanPassive13G/A

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
RNXT75989R107